What is the official ID of this bill?
The official print number for this legislation is S 1373.
Naloxone Affordability Act: Studying Costs and Access to Opioid Overdose Reversal Drug.
This bill aims to improve access to naloxone, a critical medication used to reverse opioid overdoses. It mandates a detailed government study to assess how health insurance plans (private, Medicare, Medicaid) cover over-the-counter naloxone. The goal is to identify steps that can be taken to reduce the out-of-pocket costs for citizens purchasing this life-saving drug.
Key points
Requires a federal study on the coverage and consumer costs of naloxone (opioid overdose reversal medication).
The study will analyze how private insurance, Medicare, and Medicaid cover over-the-counter naloxone.
The objective is to protect access and reduce the purchase cost of naloxone for individuals.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.